Pyroglutamate Amyloid β (Aβ) Aggravates Behavioral Deficits in Transgenic Amyloid Mouse Model for Alzheimer Disease

Pyroglutamate-modified Aβ peptides at amino acid position three (Aβ(pE3–42)) are gaining considerable attention as potential key players in the pathogenesis of Alzheimer disease (AD). Aβ(pE3–42) is abundant in AD brain and has a high aggregation propensity, stability and cellular toxicity. The aim o...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wittnam, Jessica L., Portelius, Erik, Zetterberg, Henrik, Gustavsson, Mikael K., Schilling, Stephan, Koch, Birgit, Demuth, Hans-Ulrich, Blennow, Kaj, Wirths, Oliver, Bayer, Thomas A.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Biochemistry and Molecular Biology 2012
Matèries:
Molecular Bases of Disease
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3318696/
https://ncbi.nlm.nih.gov/pubmed/22267726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/jbc.M111.308601
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars